NOVEL HIGHTHROUGHOUT SCREENING ASSAY

Information

  • Research Project
  • 6016532
  • ApplicationId
    6016532
  • Core Project Number
    R43CA080563
  • Full Project Number
    1R43CA080563-01A1
  • Serial Number
    80563
  • FOA Number
  • Sub Project Id
  • Project Start Date
    1/7/2000 - 25 years ago
  • Project End Date
    6/30/2001 - 24 years ago
  • Program Officer Name
    LEES, ROBERT
  • Budget Start Date
    1/7/2000 - 25 years ago
  • Budget End Date
    6/30/2001 - 24 years ago
  • Fiscal Year
    2000
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    1/7/2000 - 25 years ago
Organizations

NOVEL HIGHTHROUGHOUT SCREENING ASSAY

DESCRIPTION: (adapted from applicant's abstract) The aim of this SBIR proposal is to develop a novel, rapid, homogeneous assay for high throughput screening which is capable of detecting affinity interactions between antibody/antigen, receptor/ligand, and enzyme/substrate. High throughput screening (HTS) assays based on this new technology will have applications in pharmaceutical and biotechnology combinatorial drug discovery programs. The specific aims will be to develop novel reagents used in the assay, optimize assay conditions and develop instrumentation for performing the assay. The HTS assay combines the use of specially formulated photosynthetic membrane and fluorescence detection. The proposed work will focus on developing an HTS assay for identification of inhibitors of protein tyrosine kinases involved in signal transduction. An assay will be developed to identify inhibitors of src, an oncogenic protein tyrosine kinase overexpressed in certain cancer cells. PROPOSED COMMERCIAL APPLICATION: The high throughput screening assay has commercial applications in drug discovery programs and will be marketed to pharmaceutical and biotechnology companies. The technology can also be developed for application in vitro diagnostic assays for use in the biomedical, food, dairy and environmental industries.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    100001
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
    NCI:100001\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SYMBIOTECH, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    WALLINGFORD
  • Organization State
    CT
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    06492
  • Organization District
    UNITED STATES